SE9301057L - Beredning med kontrollerad frisättning - Google Patents

Beredning med kontrollerad frisättning

Info

Publication number
SE9301057L
SE9301057L SE9301057A SE9301057A SE9301057L SE 9301057 L SE9301057 L SE 9301057L SE 9301057 A SE9301057 A SE 9301057A SE 9301057 A SE9301057 A SE 9301057A SE 9301057 L SE9301057 L SE 9301057L
Authority
SE
Sweden
Prior art keywords
morphine
controlled release
preparations
manufacture
serum concentration
Prior art date
Application number
SE9301057A
Other languages
English (en)
Swedish (sv)
Other versions
SE9301057D0 (sv
Inventor
Birgitta Olsson
Maritta Anneli Pesonen
Gert Ragnarsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20389415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9301057(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9301057A priority Critical patent/SE9301057L/xx
Publication of SE9301057D0 publication Critical patent/SE9301057D0/xx
Priority to US08/213,518 priority patent/US5614218A/en
Priority to EP94912116A priority patent/EP0642335B2/de
Priority to CZ942986A priority patent/CZ284924B6/cs
Priority to NZ263632A priority patent/NZ263632A/en
Priority to DE69423028T priority patent/DE69423028T3/de
Priority to PCT/SE1994/000264 priority patent/WO1994022431A1/en
Priority to CA002135639A priority patent/CA2135639C/en
Priority to HU9403437A priority patent/HU227344B1/hu
Priority to KR1019940704397A priority patent/KR100316206B1/ko
Priority to PT94912116T priority patent/PT642335E/pt
Priority to PL94306421A priority patent/PL175326B1/pl
Priority to JP52197694A priority patent/JP4107678B2/ja
Priority to SK1437-94A priority patent/SK280362B6/sk
Priority to AU64393/94A priority patent/AU680891C/en
Priority to ES94912116T priority patent/ES2144516T5/es
Priority to AT94912116T priority patent/ATE189771T1/de
Priority to CN94190160A priority patent/CN1104891C/zh
Priority to DK94912116T priority patent/DK0642335T4/da
Priority to RU94046147A priority patent/RU2136283C1/ru
Publication of SE9301057L publication Critical patent/SE9301057L/xx
Priority to EE9400376A priority patent/EE03147B1/xx
Priority to FI945621A priority patent/FI113743B/fi
Priority to NO944565A priority patent/NO310015B1/no
Priority to LVP-94-228A priority patent/LV10684B/xx
Priority to US08/844,556 priority patent/US5952005A/en
Priority to GR20000401009T priority patent/GR3033325T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE9301057A 1993-03-30 1993-03-30 Beredning med kontrollerad frisättning SE9301057L (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE9301057A SE9301057L (sv) 1993-03-30 1993-03-30 Beredning med kontrollerad frisättning
US08/213,518 US5614218A (en) 1993-03-30 1994-03-16 Controlled release preparation
DK94912116T DK0642335T4 (da) 1993-03-30 1994-03-24 Morphinsaltholdigt præparat med styret frigivelse
RU94046147A RU2136283C1 (ru) 1993-03-30 1994-03-24 Препарат с контролируемым высвобождением лекарства и способ его получения, способ лечения
PL94306421A PL175326B1 (pl) 1993-03-30 1994-03-24 Preparat doustny wielojednostkowy o kontrolowanym uwalnianiu zawierający morfinę i sposób wytwarzania preparatu doustnego wielojednostkowego o kontrolowanym uwalnianiu zawierającego morfinę
ES94912116T ES2144516T5 (es) 1993-03-30 1994-03-24 Preparacion con liberacion controlada que contiene una sal de morfina.
NZ263632A NZ263632A (en) 1993-03-30 1994-03-24 Oral sustained release morphine composition having a barrier coating comprising at least one water insoluble compound
DE69423028T DE69423028T3 (de) 1993-03-30 1994-03-24 Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält
PCT/SE1994/000264 WO1994022431A1 (en) 1993-03-30 1994-03-24 Controlled release preparation containing a salt of morphine
CA002135639A CA2135639C (en) 1993-03-30 1994-03-24 Controlled release preparation containing a salt of morphine
HU9403437A HU227344B1 (en) 1993-03-30 1994-03-24 Oral pharmaceutical preparation containing a salt of morphine and process for producing them
KR1019940704397A KR100316206B1 (ko) 1993-03-30 1994-03-24 모르핀의염을함유하는방출조절식제제
PT94912116T PT642335E (pt) 1993-03-30 1994-03-24 Preparacao de um sal de morfina de libertacao controlada
EP94912116A EP0642335B2 (de) 1993-03-30 1994-03-24 Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält
JP52197694A JP4107678B2 (ja) 1993-03-30 1994-03-24 制御放出製剤
SK1437-94A SK280362B6 (sk) 1993-03-30 1994-03-24 Orálny farmaceutický prostriedok obsahujúci terape
AU64393/94A AU680891C (en) 1993-03-30 1994-03-24 Controlled release preparation containing a salt of morphine
CZ942986A CZ284924B6 (cs) 1993-03-30 1994-03-24 Prostředek s řízeným uvolňováním, který obsahuje morfinovou sůl
AT94912116T ATE189771T1 (de) 1993-03-30 1994-03-24 Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält
CN94190160A CN1104891C (zh) 1993-03-30 1994-03-24 缓释制剂
EE9400376A EE03147B1 (et) 1993-03-30 1994-11-16 Kontrollitud vabanemisega preparaat ja selle valmistamismeetodid
NO944565A NO310015B1 (no) 1993-03-30 1994-11-29 Preparat med regulert frigjörelse som inneholder et morfinsalt, fremgangsmåte for fremstilling derav, samt anvendelse av preparatet for fremstilling av et medikament
FI945621A FI113743B (fi) 1993-03-30 1994-11-29 Menetelmä säädetysti vapauttavan valmisteen valmistamiseksi
LVP-94-228A LV10684B (en) 1993-03-30 1994-11-30 Controlled release preparation containing a salt of morphine
US08/844,556 US5952005A (en) 1993-03-30 1997-04-21 Controlled release preparation for administering morphine
GR20000401009T GR3033325T3 (en) 1993-03-30 2000-04-26 Controlled release preparation containing a salt of morphine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9301057A SE9301057L (sv) 1993-03-30 1993-03-30 Beredning med kontrollerad frisättning

Publications (2)

Publication Number Publication Date
SE9301057D0 SE9301057D0 (sv) 1993-03-30
SE9301057L true SE9301057L (sv) 1994-10-01

Family

ID=20389415

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9301057A SE9301057L (sv) 1993-03-30 1993-03-30 Beredning med kontrollerad frisättning

Country Status (25)

Country Link
US (1) US5614218A (de)
EP (1) EP0642335B2 (de)
JP (1) JP4107678B2 (de)
KR (1) KR100316206B1 (de)
CN (1) CN1104891C (de)
AT (1) ATE189771T1 (de)
AU (1) AU680891C (de)
CA (1) CA2135639C (de)
CZ (1) CZ284924B6 (de)
DE (1) DE69423028T3 (de)
DK (1) DK0642335T4 (de)
EE (1) EE03147B1 (de)
ES (1) ES2144516T5 (de)
FI (1) FI113743B (de)
GR (1) GR3033325T3 (de)
HU (1) HU227344B1 (de)
LV (1) LV10684B (de)
NO (1) NO310015B1 (de)
NZ (1) NZ263632A (de)
PL (1) PL175326B1 (de)
PT (1) PT642335E (de)
RU (1) RU2136283C1 (de)
SE (1) SE9301057L (de)
SK (1) SK280362B6 (de)
WO (1) WO1994022431A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
AU735113C (en) * 1991-12-24 2007-06-14 Mundipharma Medical Gmbh Opioid formulations for treating pain
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL109944A (en) † 1993-07-01 1998-12-06 Euro Celtique Sa Sustained release dosage unit forms containing morphine and a method of preparing these sustained release dosage unit forms
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2295043A1 (de) 1999-10-29 2011-03-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
WO2003024429A1 (en) 2001-09-21 2003-03-27 Egalet A/S Polymer release system
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20050020613A1 (en) * 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
SI1551372T1 (en) * 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
US20040138200A1 (en) * 2002-10-04 2004-07-15 Michael Hawley Pharmaceutical compositions for treatment of Parkinson's disease
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US8877241B2 (en) 2003-03-26 2014-11-04 Egalet Ltd. Morphine controlled release system
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
CN1819821B (zh) * 2003-08-08 2010-10-13 拜奥维尔实验室国际股份有限公司 盐酸安非他酮的改良释放片剂
EP1810678A1 (de) 2006-01-19 2007-07-25 Holger Lars Hermann Verwendung einer Kombination von Morphin und Naloxon zur Drogensubstitution
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CN105534936B (zh) * 2007-08-13 2020-07-31 Ohemo 生命科学股份有限公司 抗滥用药物、使用方法和制备方法
GB2460915B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
EP2568977A1 (de) 2010-05-11 2013-03-20 Cima Labs Inc. Alkoholresistente metoprololhaltige orale retard-dosierformen
US20120009261A1 (en) 2010-07-06 2012-01-12 Grünenthal GmbH Novel gastro-retentive dosage forms
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
US20140275038A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US12161754B2 (en) 2017-12-20 2024-12-10 Purdue Pharma L.P. Abuse deterrent morphine sulfate dosage forms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
SE8902699D0 (sv) * 1989-08-09 1989-08-09 Lejus Medical Ab Diltiazem containing pharmaceutical compositios
DE4105480A1 (de) * 1991-02-21 1992-08-27 Boehringer Mannheim Gmbh Verbesserte aktivierung von rekombinanten proteinen
US5478577A (en) † 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5273760A (en) † 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
SE9202250D0 (sv) * 1992-07-29 1992-07-29 Gacell Lab Ab Controlled release morphine preparation

Also Published As

Publication number Publication date
RU94046147A (ru) 1996-11-10
NZ263632A (en) 1997-06-24
EP0642335A1 (de) 1995-03-15
EP0642335B1 (de) 2000-02-16
AU6439394A (en) 1994-10-24
GR3033325T3 (en) 2000-09-29
LV10684A (lv) 1995-06-20
DE69423028T3 (de) 2006-07-20
DK0642335T4 (da) 2005-05-23
KR100316206B1 (ko) 2002-11-09
PL306421A1 (en) 1995-04-03
DE69423028T2 (de) 2001-01-18
JP4107678B2 (ja) 2008-06-25
FI945621A0 (fi) 1994-11-29
WO1994022431A1 (en) 1994-10-13
DK0642335T3 (da) 2000-07-24
FI945621L (fi) 1994-11-29
AU680891B2 (en) 1997-08-14
FI113743B (fi) 2004-06-15
HU9403437D0 (en) 1995-02-28
AU680891C (en) 2002-01-03
NO310015B1 (no) 2001-05-07
NO944565D0 (no) 1994-11-29
CZ284924B6 (cs) 1999-04-14
SK280362B6 (sk) 1999-12-10
ATE189771T1 (de) 2000-03-15
ES2144516T3 (es) 2000-06-16
SK143794A3 (en) 1995-06-07
RU2136283C1 (ru) 1999-09-10
LV10684B (en) 1996-02-20
CZ298694A3 (en) 1995-05-17
HUT71417A (en) 1995-11-28
ES2144516T5 (es) 2005-07-01
CA2135639C (en) 2006-02-07
CA2135639A1 (en) 1994-10-13
NO944565L (no) 1994-11-29
EP0642335B2 (de) 2005-01-19
HU227344B1 (en) 2011-04-28
DE69423028D1 (de) 2000-03-23
EE03147B1 (et) 1999-02-15
US5614218A (en) 1997-03-25
PT642335E (pt) 2000-08-31
CN1104891C (zh) 2003-04-09
CN1106608A (zh) 1995-08-09
JPH08501319A (ja) 1996-02-13
SE9301057D0 (sv) 1993-03-30
PL175326B1 (pl) 1998-12-31

Similar Documents

Publication Publication Date Title
DK0642335T4 (da) Morphinsaltholdigt præparat med styret frigivelse
NZ508526A (en) Opioid formulations for treating pain
NZ509028A (en) Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film
CA2098738A1 (en) Controlled Release Oxycodone Compositions
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
EP0866656A4 (de) Inhibierung des alpha tumornekrose-faktors
GEP20002229B (en) Synthetic Membrane Vesicles, Method for Obtaining and Application of the Same
GEP19991686B (en) Pharmaceutical Composition for Obtaining Effervescent Powder or Tablet, Pharmaceutical Preparation and Method for Preparing Same
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
MY124465A (en) Reduction of infarct volume using citicoline
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
US5082665A (en) Anti-snoring formulations using yohimbine
WO1997025049A1 (en) Composition containing diosgenin
HUP9900521A2 (hu) Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
Mooser et al. Antihypertensive effect of diltiazem administered once and twice daily
RU94045317A (ru) Способ лечения вилюйского энцефаломиелита
MY114610A (en) Controlled drug delivery system for diltiazem.
MY110769A (en) Controlled release oxycodone compositions.
CA2012257A1 (en) Anti-snoring formulations
RU95120783A (ru) Способ профилактики и лечения атеросклероза
RU97109989A (ru) Способ лечения вагинозов и вагинитов у беременных

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9301057-7

Format of ref document f/p: F